Real-Time Imaging of Tumors Using Replication-Competent Light-Emitting Microorganisms
Early detection of cancer and metastases is pivotal to the success of subsequent treatment intervention. In recent years, the use of live microorganisms, such as viruses and bacteria, has gained substantial research and clinical interest in both detection and therapy of cancer. Many of these live microorganisms have shown remarkable tumor-specific replication following systemic delivery. With the aid of modern molecular technologies, modified live microorganisms can be engineered to carry additional diagnostic and therapeutic capabilities. We have shown that when armed with light-emitting protein genes, such as genes for luciferase and green fluorescent protein, the entry and specific amplification of systemically-delivered vaccinia virus and bacteria in tumors can be visualized in real time using a low-light imager, or using macro- and micro-fluorescence microscopes. Therefore, through optical imaging, the location of tumors and metastases could be revealed by these light-emitting microorganisms. The tumor-colonization capability has been demonstrated in both immuno-competent as well as immuno-compromised rodent models with syngeneic and allogeneic tumors. Based on their “tumor-finding” nature, bacteria and viruses could be further designed as “vehicles” to carry multiple genes for detection and therapy of cancer.
Key wordsVaccinia virus Bacteria Systemic delivery Tumors Metastases GFP Luciferase Fluorescence and luminescence imaging
This work was supported by an internal research grant from Genelux Corporation. The authors would like to thank Qian Zhang, Nanhai Chen, and Terry Trevino for scientific and technical contributions, and Kim Duffy for editorial assistance.
- 8.Kelly, K., Brader, P., Woo, Y., Li, S., Chen, N., Yu, Y. A., Szalay, A. A., and Fong, Y. (2009) Real-time intraoperative detection of melanoma lymph node metastases using recombinant vaccinia virus GLV-1h68 in an immunocompetent animal model. Int. J. Cancer. 124, 911–918.PubMedCrossRefGoogle Scholar
- 9.Chen, N., Zhang, Q., Yu, Y. A., Stritzker, J., Brader, P., Schirbel, A., Samnick, S., Serganova, I., Blasberg, R., Fong, Y., Szalay, A. A. (2009) A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging. Mol. Med. 15, 144–151.PubMedCrossRefGoogle Scholar
- 10.Brader, P., Kelly, K. J., Chen, N., Yu, Y. A., Zhang, Q., Zanzonico, P., Burnazi, E. M., Ghani, R. E., Serganova, I., Hricak, H., Szalay, A. A., Fong, Y., Blasberg, R. G. (2009) Imaging a genetically engineered oncolytic vaccinia virus (GLV-1h99) using a human norepinephrine transporter reporter gene. Clin. Cancer Res. 15, 3791–3801.PubMedCrossRefGoogle Scholar
- 11.Brader, P., Stritzker, J., Riedl, C. C., Zanzonico, P., Cai, S., Burnazi, E. M., Ghani, E. R., Hricak, H., Szalay, A. A., Fong, Y., Blasberg, R. (2008) Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin. Cancer Res. 14, 2295–2302.PubMedCrossRefGoogle Scholar
- 13.Zhang, Q., Liang, C., Yu, Y. A., Chen, N., Dandekar, T., Szalay, A. A. (2009) The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation. Mol. Genet. Genomics. 282, 417–435.Google Scholar
- 14.Voisey, C. R., and Marincs, F. (1998) Elimination of internal restriction enzyme sites from a bacterial luminescence (luxCDABE) operon. Biotechniques 24, 56–58.Google Scholar
- 21.Hoffman, R. M. (2005) The multiple uses of fluorescent proteins to visualize cancers in vivo. Nat. Rev. Cancer 5, 794–806.Google Scholar
- 22.Hoffman, R. M. and Yang, M. (2006) Whole-body imaging with fluorescent proteins. Nat. Protoc. 1, 1429–1438.Google Scholar
- 23.Hoffman, R. M. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest. New Drugs 17, 343–359.Google Scholar